# Capravirine to Treat Children With HIV Infection

> **NCT00006519** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 96 (—)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Capravirine

## Key facts

- **NCT ID:** NCT00006519
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 96 (—)
- **Last updated:** 2006-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006519, "Capravirine to Treat Children With HIV Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00006519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*